Infectious diseases continue to pose a significant burden on global health systems, requiring rapid innovation and resilient research frameworks. At mediSMART, we are committed to accelerating the development of preventive and therapeutic solutions through high-quality clinical trials in infectious diseases.

We support phase I–IV clinical studies across a wide spectrum of infectious disease areas, including:

🦠 COVID-19 and emerging viral infections

🧬 HIV/AIDS

🫀 Hepatitis B and C

🫁 Tuberculosis (TB)

🔬 Bacterial infections and antimicrobial resistance (AMR)

🍄 Fungal infections

💉 Vaccines for adults and pediatrics

✈️ Travel and tropical diseases

Our network includes infectious disease specialists, epidemiologists, and public health-focused research teams, ensuring comprehensive support from site activation to data collection and reporting.

mediSMART's operational excellence, regulatory expertise, and extensive reach across Turkey and the MENA region make us a reliable partner for global sponsors and CROs addressing urgent infectious disease threats.